Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.

about

Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urothelium.

P2860

Q50355469-20CFD700-04E0-4EC3-A1AC-13EB119DAB33

P2860

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.

Item

http://www.wikidata.org/entity/Q36953789

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Efficacy of weekly paclitaxel ...... in urothelial bladder cancer.

@en

type

Item

label

Efficacy of weekly paclitaxel ...... in urothelial bladder cancer.

@en

prefLabel

Efficacy of weekly paclitaxel ...... in urothelial bladder cancer.

@en

P1476

Efficacy of weekly paclitaxel ...... in urothelial bladder cancer.

@en

P2093

Ahmad Awada

http://www.w3.org/2001/XMLSchema#string

Fouad Aoun

http://www.w3.org/2001/XMLSchema#string

Marc Zanaty

http://www.w3.org/2001/XMLSchema#string

Nieves Chanza Martinez

http://www.w3.org/2001/XMLSchema#string

Sofia Latifyan

http://www.w3.org/2001/XMLSchema#string

Spyridon Sideris

http://www.w3.org/2001/XMLSchema#string

Thierry Gil

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

Docetaxel and ifosfamide as second line treatment for patients with advanced or metastatic urothelial cancer after failure of platinum chemotherapy: a phase 2 study.

Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network.

Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.

Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study.

Paclitaxel Carboplatin chemotherapy as a second-line chemotherapy for advanced platinum resistant urothelial cancer in Japanese cases.

Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma.

Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987.

Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma.

P304

1063-1067

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2016.821

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

298805734

http://www.w3.org/2001/XMLSchema#string

P698

27284445

http://www.w3.org/2001/XMLSchema#string

P932

4887921

http://www.w3.org/2001/XMLSchema#string

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.

about

P2860

P2860

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932